Novel Coronavirus (SARS-CoV-2/COVID-19)

While hospitals and health systems — and their brave front-line caregivers — continue to battle the greatest public health challenge of our lifetimes, the Department of Health and Human Services recently made a change to its COVID-19 Provider Relief Fund (PRF) reporting requirements that could…
The Department of Health and Human Services Assistant Secretary for Preparedness and Response has released a recording of its Sept. 24 webinar on strategies to optimize personal protective equipment and supplies during the COVID-19 public health emergency.
A vast majority of nurse leaders (86%) feel prepared for a future COVID-19 surge, according to more than 1,800 nurse leaders the AHA’s American Organization for Nursing Leadership surveyed in July about pandemic preparedness and other key issues.
The Food and Drug Administration posted updated comparative performance data for molecular tests to diagnose the COVID-19 virus.
Beginning October 1, American hospitals can purchase Veklury (remdesivir) directly from the drug’s distributor, the Department of Health and Human Services announced today.
The Department of Health and Human Services today announced the availability of $20 billion to hospital and providers through the third Provider Relief Fund general distribution. The application period begins Oct. 5.
The Department of Health and Human Services (HHS) today announced the forthcoming distribution to all hospitals, as well as other providers, of $20 billion in funds from the Public Health and Social Services Emergency Fund
Dr. Estes talks with Dr. David W. Zaas, CEO of MUSC Health - Charleston Division and Chief Clinical Officer for MUSC Health, to discuss COVID-19’s impact on health trends and services in South Carolina.
An experimental mRNA vaccine for the COVID-19 virus generated a strong immune response in older adults in a phase 1 clinical trial, who generally tolerated it well, the National Institutes of Health reports.
The National Institutes of Health has awarded nearly $234 million to improve COVID-19 testing for underserved and vulnerable populations, such as African Americans, American Indians/Alaskan Natives, Latinos/Latinas, Native Hawaiians, older adults, pregnant women and those who are homeless or…